Amsterdam, the Netherlands Thursday, April 10, 2025, 18:00 Hrs [IST] ...

US FDA inspects Science 37’s Direct-to-Patient Site for clinical research in phase 3 asthma trial; no objectionable conditions noted: Morrisville, N.C. Thursday, April 10, 2025, ...

OneSource’s unit 2 facility in Bengaluru gets Brazilian Health Regulatory Agency approval: Our Bureau, Mumbai Thursday, April 10, 2025, 15:50 Hrs [IST] OneSource Specialty Pharm ...

Bayer seeks EMA approval for aflibercept 8 mg for treatment of retinal vein occlusion: Berlin Thursday, April 10, 2025, 16:00 Hrs [IST] Bayer has submitted an application to the E ...

Avidity Biosciences receives Japan MHLW’s orphan drug status for delpacibart etedesiran to treat myotonic dystrophy type 1: San Diego Thursday, April 10, 2025, 13:00 Hrs [IST] A ...

Nyxoah updates on US FDA approvable letter for Genio system to treat obstructive sleep apnea: Mont-Saint-Guibert, Belgium Thursday, April 10, 2025, 14:00 Hrs [IST] Nyxoah SA, a me ...

Bristol Myers Squibb’s Opdivo plus Yervoy gets US FDA nod to treat adult and pediatric patients with mismatch repair deficient colorectal cancer: Princeton, N.J. Thursday, April ...

CPHI Americas 2025, which is committed to empowering the next generation of pharmaceutical professionals, and has announced a new Emerging Professional badge, offering learning, networking, and career ...

AstraZeneca to showcase innovation in infectious disease protection at ESCMID Global 2025: Cambridge, UK Thursday, April 10, 2025, 15:00 Hrs [IST] AstraZeneca will share new data ...

Logistics4Pharma expands customs services with temporary storage and transit document management: Frankfurt Thursday, April 10, 2025, 12:00 Hrs [IST] Logistics4Pharma, a Frankfurt ...

Sanofi announces tolebrutinib phase 3 study data published in NEJM shows benefit on disability progression in multiple sclerosis: Paris Thursday, April 10, 2025, 10:00 Hrs [IST] T ...

Peethaambaran Kunnathoor, Chennai Thursday, April 10, 2025, 08:00 Hrs [IST] ...